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Eppinger Prize Lecture: On Liver Transplantation* 
TH. E. STARZL 
Since receiving the news of the Eppinger Award, I have thought more than 
once about the ties that bind the United States to Europe, how immediate are 
the connections of most American citizens to a European culture and society, 
and the indebtedness which all of us have to our forebears. There is a minor 
literary classic by Thornton Wilder called "The Bridge of San Luis Rey". The 
central incident in this book is the collapse of a bridge in South America, with 
the death of several travelers. The number of lives lost was not great, but the 
influence of these people on their communities and therefore the world was far 
from trivial. By means of acts of love or compassion, their personalities had 
effected other lives and had become pervasive like the ripples in a tranquil pond 
into which a stone had been thrown. 
I know the same thing could be said about Professor HANS EpPINGER. By the 
time the photograph in Fig. 1 was taken, his eyes reflected the sadness of a 
series of insupportable losses including those of his only son and his grandson 
during the Second World War. He did not have long to live in earthly terms 
and yet it is quite evident from the nature of today's meeting that he is still 
with us in spirit. I would like to acknowledge my own debt to Professor 
EpPINGER with a bit of petite histoire that illustrates well the thesis of Thornton 
Wilder. 
More than 20 years ago as a medical student at Northwestern University in 
Chicago, I attended a series of pathology seminars conducted at the Cook 
County Hospital by Professor HANS POPPER, one of EpPINGER'S pupils. I 
remember particularly well an autopsy performed for the class by Dr. POPPER 
on a patient who had died of post-necrotic cirrhosis. It excited in me an interest 
in liver disease which has persisted until now. The thousands of others who 
were eventually taught by EpPINGER'S students now are part of the growing 
chain by which this man's influence will further spread. It is not hard to see 
why he is held in such honor. 
* Supported by United States Public Health Service grants AI-04152, AM-12148, 
AM-07772, RR-00051, RR-00069, AI-AM-08898, HE-09110, and GM-01686. 
Th. E. Starzl 
Fig. 1. Professor HAl'S EpPINGER, 1UT9~194SK [By reproduction from Wien. Idin. Wschr. 
78: 674 (196fj).] 
Mter these introductory remarks, it may be superfluous to say that the topic 
of my presentation concerns the liver and specifically, transplantation. In 
discussing the subject, I would like to convey some sense of the experimental 
background of such procedures, to comment about the immunosuppressive 
treatment that is required for success, and most importantly to review the 
evolving attitudes about the indications for clinical transplantation. 
Auxiliary transplantation 
It should be stressed that there are 2 fundamentally different kinds of 
hepatic transplantation procedures. In one, first described in dogs by C. Stuart 
Welch of Albany, New York, the host liver is not disturbed and the new organ 
is placed in some abnormal location. The heterotopic sites have included the 
paravertebral gutter (Fig. 2), the splenic fossa, and the pelvis. Providing an 
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Fig.2. Auxiliary liver transplantation in dogs by a modification of WELCH'S original 
technique. Note that the reconstituted portal blood supply is from the distal inferior vena 
cava. Cholecystoduodenostomy is performed. [By permission of Ann. Surg. 160: 411 (1 g64).] 
arterial supply under these circumstances is not difficult. However, establish-
ment of an inflow to the portal vein has special metabolic implications. 
I nterliver competition 
The significance of the source of portal blood supply was realized in 1963 and 
1964 when auxiliary canine livers were transplanted by techniques similar to 
that shown in Fig. 2. The portal venous inflow was taken from the distal 
inferior vena cava or an iliac vein, establishing in essence a blood supply for 
these homografts like that after the experimental procedure of portacaval 
transposition. Somewhat to our surprise the transplanted livers quickly 
underwent major atrophy. The gross appearance and lobar proportions of the 
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now diminutive homografts remained relatively unaltered except for size 
(Fig. 3). Histopathologically, the major finding was a massive loss of hepato-
cytes. The duct system did not participate in the shrinkage and, if effective 
immunosuppression was provided, it often was more or less completely spared 
from rejection. 
An explanation for these findings was subsequently provided by a series of 
papers from our laboratory which showed that two co-existing livers could 
engage in competition to their mutual disadvantage. Conditions favoring one 
organ over the other included the kind of portal venous blood; it was best for 
the source of this blood to be the effluent returning from the intestine rather 
than from some other capillary bed. Other factors included the quantity of 
portal venous flow, the presence or absence of biliary obstruction, and the 
magnitude of rejection to which the homograft was subjected. Depending on 
the circumstance, one of the livers usually could be shown to flourish whereas 
the other organ, which was laboring under a physiologic handicap of one kind 
or other, underwent atrophy. 
t.S days 
3-9-6t. 
Fig.3. The auxiliary homograft (right) and the recipient dog's own liver (left) in an 
experiment in whioh the host and trall~pganted organs had originally been about the same 
size. The method of revasoularization was as illustrated in Fig. 2. Postoperative immuno-
suppression was with azathioprine. Note the well preserved but dimensionally reduoed 
general struoture of the homograft. The gallbladder did not shrink proportionately. The 
specimens were obtained 45 days after transplantation. [By permission of Ann. Surg. 160: 
411 (1964).] 
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Fig. 4. An experiment designed to show the effect of splanchnic venous blood upon the 
liver (partial portacaval transposition). Note that one portion of the livcr received venous 
blood from the intestinal effluent, hut that the other part derived its portal inflow from 
the inferior vena caya. [By permission of Surgery 61: 723 (19G7).] 
Some of the best information about interliver competition has come from 
experiments in which dog livers have been divided into two portions using a 
preparation known as "split transposition" in which one of the portal radicles 
is fed with systemic venous blood and the other with splanchnic blood (Fig.4). 
Immunologic effects in this model are eliminated making it possible to accu-
rately study the influence of such things a,s splanchnic venous versus systemic 
blood. 'With the split transposition preparation, the concept of interliver 
competition which I have just described was confirmed beyond all reasonable 
doubt. I might say that these disclosures confirmed a general hypothesis that 
had been clearly stated by the Dutchman, L. SCHALM, and others a number of 
years earlier before its great significance for auxiliary liver transplantation was 
ever thought of. 1) 
Clinical experience 
In human candidates for hepatic transplantation, it may be assumed that the 
host liver will have been rendered relatively non-competitive by the disease for 
which treatment is indicated, the question being only one of degree. Conse-
quently, the principle of interliver compctition is probably less important in the 
clinical situation than in experimental animals. Nevertheless, the results with 
auxiliary transplantation in patients have been extremely discouraging. The 
longest survival in any patient treated for hepatic insufficiency has been only 
1) The literature, concerning this point and other aspects of both auxiliary and ortho-
topic transplantations, is completely annotated in a recent book (1). 
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34 days (Fig. 5). In this case, the host disease was Laennec's cirrhosil3. Mter 
auxiliary transplantation, there was immediate homograft function with clea-r-
ing of the hyperbiliru binemia as well as obvious prothrombin synthesis (.Fig. 5). 
Later, a rejection developed with secondary deepening of jaundice and finally 
death from infection. FORTNER of New York City has recently reported that a-
patient with carcinoma of the hepatic ducts lived for 240 days after auxiliary 
transplantation. The role, if any, that the second liver played in this 8 month 
survival is not clear since the patient at the time of operation was not dying of 
hepatic insufficiency, the main complaint being of jaundice. Eventually the 
cause of death was cholangitis of the obstructed host liver, a complication to 
which immunosuppression might actually be expected to contribute. 
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Fig. 5. The course of a patient who recei\"ed an auxiliary hepi'ltic homograft that was 
vascularized by a t.echnique similar to that shown in Figure 2. There was apparently 
good initial function which later deteriorated when rejcction was not controlled. Note thc 
rapid development of azotemia late in the course. The gastroint.estinal bleeding which was 
the immediate cause of death was due to widespread intestinal moniliasis; the exploratory 
laparotomy was made in an effort to control the bleeding. Immunosuppressive therapy in 
t.his patient was with azathioprine and prednisone. Profound leukopenia developed in the 
fomth postoperatiYe week. The patient died of infection. (By permission of ",,'. B. Saunders 
Co.) 
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Fig. 6. Techniques of orthotopic liver transplantation. A, The kind of arterial anastomosis 
most commonly used. The homograft celiac axis or common hepatic artery is 8.ttached to 
the proper or common hcpatic artery of the recipient. B, Arterial reconstruction of two 
homograft arteries. The vcssels are individually anastomosed to the branches of the 
recipient proper hepatic artery. C, Anastomoses of the homograft aorta to the recipient 
aorta. The variation has been used in the presence of a double arterial supply to the 
transplanted liver. [By permission of Ann. Surg. 168: 392 (1968).] 
Our own animal research into the matter of auxiliary liver transpla,ntation 
dates back almost eight years. In addition, we have tried to treat 4 patients 
with auxiliary homografts, the first time almost 6 years ago. If only for these 
reasons, I would hate to be considered a nihilist about the possibility of using 
this "conservative" approach to treatment. Yet, I must concede that auxiliary 
transplantation has yielded inferior results in laboratory animals in comparison 
to liver replacement, that it has not been an effective procedure in man, and 
that there has been no proven instance in ~which the life of a patient has been 
meaningfully prolonged. Moreover, I will be telling you about some additional 
observations in patients whose diseased livers were removed and replaced that 
further weaken the case for the concept of an auxiliary organ. These discourag-
ing statements should serve as my summary comment about auxiliary trans-
plantation as well as an introduction to a discussion of orthotopic transplanta-
tion. 
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Orthotopic transplantation 
With orthotopic transplantation, the diseased host liver is removed and 
replaced. In principle, the operation could hardly be more straight forward 
since the anatomic structures entering and leaving the hepatic homograft are 
reconstructed in as anatomically a normal arrangement as possible. There are 
usually four vascular anastomoses, the vena cavae above and below the liver, 
tho portal vein and the hepatic artery (Fig. 6). Because of its ease of performance 
and freedom from a need for drains or tubes, we usually use cholecystoduodeno-
stomy to provide for biliary drainage (Fig. 6). 
I do not wish to convey the impression that liver replacement should be 
attempted by people of minor surgical experience or by those who have not 
recapitulated the important technical lessons that can be easily learned in the 
experimental laboratory. In patients, the presence of intrinsic hepatic disease, 
the resulting portal hypertension, and the defective clotting which is often 
present may make liver replacement ono of surgery's most formidable technical 
undertakings. 
1000 cold lactated Rinqrzl'$ 
with 1 Ql"am procaine. chloridrz 
l g~gy 
r 
Fig. 7. Infusion of tho portal vein of an excised hepatio hornograft with a chilled electrolyte 
solution. In reoent years dextran has been added for onootic oontrol. [By permission of 
Smg. Gynec. Obstet.117: 659 (1963).] 
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Fig. 8. Technique of extracorporeal perfusion with a heart.lung machine. Catheters are 
inserted via the femoral vessels into the aorta and vena cava as soon as possible after death. 
The extracorporeal circuit is primed with a glucose or electrolyte solution to which 
procaine and hcparin are added. The cadaver is thus anticoagulated with the first surge 
of the pump. Temperature control is provided by the heat exchanger. Cross clamping the 
thoracic aorta limits perfusion to the lower part of the body. (By permission of W. B. Saun-
ders Co.) 
Organ preservation 
A critical issue in transplantation of the liver is the quality of the organ to be 
used. In the first human trials in 1963 and 1964, the liver homografts were quite 
badly damaged by ischemia incurred both pre- and postmortem. Today, with 
acceptance in most centers of the concept of brain death, this is less apt to 
happen. If a liver is excised under the conditions of brain death in which an 
effective hepatic circulation may be present during the actual organ removal, 
the liver can simply be cooled by infusing a chilled solution through the portal 
vein (Fig. 7); the resulting safe preservation time is more than 2 hours. Should 
circulation fail, either before or during hepatectomy, an artificial circulation can 
be provided with a stand-by heart-lung machine. If a heart exchanger is built into 
the apparatus, the corpse can be cooled as the organ removal is proceeding 
(Fig. 8). Finally, it is worth mentioning in passing that livers have been success-
----- ----------------------------
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fully preserved in our laboratory for as long as one day after their excision with 
a combination of low flow intravascular perfusion, hyperbaric oxygenation, and 
hypothermia. 
J rmnnno,nlppress-ion and rejection 
With liver transplantation, as with the transplantation of all other organs, 
the central issue after a teE~hnically satisfactory opcration is the prevention of 
homograft rejection. In dogs, it was first demonstrated on March 23, 1964 that 
long term survival could be obtained with one of the same agents that has been 
used for renal transplantation. On that date, the dog shown in Fig. 9 had his 
Fig.9. Recipient of an orthotopic liver homograft, 5 years later. The operation was on 
March 23, 1964. The animal is still in perfect health more t.han 61/ 2 years postt,ransplanta-
tion. (By permission of IV. B. paund~rs Co.) 
own liver removed and replaced with the organ of a nonrelated mongrel donor. 
Immunosuppressive therapy was ,vith azathioprine. After 4 months, this drug 
was discontinued (Fig. 10). The dog is still alive, two-thirds of a canine lifetime 
later. The same kind of success has been achieved in dogs with the globulin 
derivative (called ALG) of horse antilymphocyte serum (ALS). In fact, there has 
been very strong evidence from the beginning of the animal experimentations 
that rejection is easier to control and that long-standing tolerance is somewhat 
easier to achieve with the liver than other organs. This has been particularly 
well demonstrated in pigs by GARXIER in Paris and confirmed by TERBLAXCHE 
of Leeds, CALNE of Cambridge, and in our own laboratories. In pigs, hepatic 
transplantation can sometimes be successfully done between nonre1ated donors 
and recipients without any immunosuppressive treatment at all. 
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Fig. 10. Course of a dog after orthotopic homotransplantation of the liver. Overt clinical 
rejection has never been observed. Liver biopsies after three, six and a half and 10 months 
were normal. The operation was performed on March 23, 1964. The animal is in good 
health more than 61/ 2 years later (see Fig.9). Note that immunosuppression was discon-
tinued afterfourpostoperative months without subsequent deterioration of liver function. 
Resumption of treatment has never been required. [By permission of Surgery 58: 131 
(1965).] 
Although it is my belief for the foregoing reasons that the liver is biologically 
somewhat favored in transplantation, it would be easy to overstate this point 
since, in patients, very severe rejection has quite often been seen, necessitating ex-
tremely aggressive treatment. I would like to illustrate two ways in which the 
process of immunologic repudiation may manifest itself. Shown in Fig. 11 is the 
course of a man treated with orthotopic liver transplantation for the indication of 
hepatoma. Liver function in the first several days was quite satisfactory. Then, 
despite combined immunosuppression with azathioprine, prednisone, and ALG, 
there ensued a savage rejection crisis. Within a day, the bilirubin rose to 15mg% 
with associated increases in the serum transaminases. At the same time, the 
patient was prostrated with fever and was demonstrated to have a gram nega-
tive septicemia. Fortunately, all the adverse findings reversed. The patient 
recovered completely and was discharged from the hospital two months later. 
During the critically important first two weeks of convalescence, liver scans 
are usually ordered every few days. Several such examinations were obtained 
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(indicated by the letters A-F) in the patient whose clinical course is summarized 
in Fig. 11. At the peak of rejection, large areas of the homograft ceascd to pick 
up the technetium isotope (Fig. 12), particularly at the time of the gram negative 
bacteremia (Fig. 12D). The "disappearing" hepatic tissue was apparently still 
viable since later scans returned to or toward normal. 
OT 15 
LIVER SCAN BC D E F. 62-t59 kg. 
METHlClWN •• 
. • 
AMPICILLIN 
KANAMYCIN 
BLOOD CULTURE e 
41 E.coli 
TEMPERATURE (0 C) 
HIGH-
LOW -----
SGOT (I.U) 
BIURUBIN 
(mg per 100 mil 
TOTAL-
CONJUGATED---
AZATHIOPRINE 
(mg) 
PREDNISONE (mg) 
ALG 
30 
DAYS 
Fig. 11. The postoperative events in patient OT 15. An explosivo rejection began on the 
sixth day, reached a peak within two days and receded promptly. Gram negative bacteremia 
was diagnosed from a blood specimen obtained on post-transplantation day 14. The liver 
scans indicated by the letters A to F are shown in Figure 12. Note that the immuno-
suppressive therapy was actually lightened with the development and evolution of the 
rejection episode. (By permission of W. B. Saunders Co.) 
Fsing the xenon washout technique, it was demonstrated several years ago 
by Dr. CARL GROTH in our laboratories that one of the features of acute rcjec-
tion of livers was a reduction in hepatic blood flow which if unreversed could 
proceed to focal or even massive necrosis. The changes in liver scans that may 
occur during an acute rejection episode in patients are undoubtably a reflection 
of such flow changes. Moreover, the pathogenesis of the bacteremia alluded to 
above was probably by the mechanism shown in Fig. 13. The illustration 
suggests that there has been injury to the hepatic parenchyma, that the bacterial 
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Fig. 12. Anteroposterior liver soa.ns ob tained with 99M-teclmetiurn in patient OT 15. Not·e 
the temporary disappearance of portions of the h om ogmft on the e il-'-ht,h and fifteenth 
postopernti ve days ; the firs t of these oooasions 'was at the beginn i ng of an explosive 
rejeotion oris is . At the time of the 15-day soan, the patient had developed gram nngative 
sq ) tioemia, presumably from a heps.tic focu s. The remittent changf's in the liver scans 
were thought to be d ue to variat io ns in hepatic blood flow during the rej ection crisis. The 
pat,ient reoovered completely from thesn f'pisodes and was dischargnd from the hospital 
65 days po,toperatively. Correlate the soans with the clinical ev"nts shown in Fig . 11 . 
(By permission of VV. B . Saunders Co.) 
filter action has been lost as a consequence , and that microorganisms indigenous 
to the gastrointestinal tract then find their way into the blood stream . If 
rejection is permitted to proceed to the point, where major hepatic necrosis 
occurs, the lethal complication of bacterial gangrene of part of the homograft is 
the inevitable consequence. 
Not all rejections are as violent as that shown in Fig. 11 and 12. A more 
indolent kind may be indistinguishable from biliary obstruction as I will men -
tion later in cOl1J1ection with a case of Wilson's disease . Finally, there may be 
significant rejection without much derange ment at all in the liver functions as 
exemplified by the course shown in Fig . 14. The patient was a child with biliary 
atresia. After transplantation , the bilirubin fell to nearly normal levels . Beginn-
ing late in the first postoperative month, there were low grade increases in the 
transaminases and alkaline phosphatase but without a recurrence of jaundice 
and with no alterations in the serum protein. 
In this form of rejection , which we have called the "anicteric" variety, serial 
liver scans may reveal a very substantial swelling of the liver homograft which 
then recedes with the waning of the immunologic attack (Fig. 15). Failure to 
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recognize that rejection of this kind was occurring in several of our early 
patients led to errors of undertreatment with the tragic results that some of 
them developed regional gangrene of their hepatic homografts. The best way to 
avoid this kind of infectious complication in the post-transplantation period is 
to use very heavy early immunosuppression . 
.Fig. 13. An explanation of the predisposition of the linT to bacterial sepsis. Presumably 
the invading microorganisms enter via the portal vein or through the reconstructed 
biliary tract. [By permission of Ann. Surg. 168: 392 (1968).] 
Indications for orthotopic transplantation 
I would now like to develop some thoughts about the results with and the 
indications for orthotopic livcr transplantation, based primarily on our own 
experience with this procedure which dates back to March 1963. 
Overall results: Our first 7 trials all resulted in the death of the patients in 
3 weeks or less. The first chronic survival was not obtained until the eighth 
attempt which was on July 20, 1967. Since then, we have had 9 patients who 
have lived for a year or longer after orthotopic liver transplantation. That is the 
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numerator shown in Table 1. The denominator shows the 33 consecutive cases 
that were complied from 1963 until late last year. Thus the uncorrected one 
year survival was 27 %. Obviously, the success rate in more recent times has 
increased. It should be emphasized that the majority of deaths occurring early 
(within the first month) have been caused by technical surgical accidents of one 
kind or other. Such complications should be avoidable in future cases with a 
greater background of experience. 
Table 1. 33 Orthotopic transplantations. 
SGQIjl.U.l 
SGP:r:_tI.Ul 
BlURUBIN 
(mg per 100 mil 
TOTAL-
CONJUGATED -----
AZATHIOPRINE 
(mgl 
PREDNISONE 
(mgl 
ALG 
One year survival: 
9/33 (27%) 
PT. R. B. 11.2 kg. 
TIME IN DAYS 
Fig. 14. Example of subclinical rejection (0'1' 13). The indication for operation was 
oxtrahepatic biliary atresia. The bilirubin fell almost immediately from more than 30 mg 
per cent to less that 5 mg pel' cent. There was no recurrence of the jaundice in the interval 
shown. However, there were rises in the alkaline phosphatase, SGOT, and SGPT from the 
third to the seventh postopl'ratiyl' weeks. Antibiotic therapy was stopped after four weeks. 
The templ'mtures shown are the maximums for each day. [By permission of Ann. Surg. 
168: 392 (1968).1 
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Fig. 16. Metastases in a liver homograft, 143 days after its orthotopic transplantation. 
Except for a very small residual area of hepatic parenchyma (arrow), the organ has b een 
replaced by r eCUTTent tumor. (By permission of W. B. Saunders Co.) 
Own liver removed 
at Tx 1/22170 
Weight: 1052 g 
Fig. 17. The JiveI' removed from a four year old child who was dying of biliary at.resia. 
A small hep8toma was fonnel in the specimen (arrows). 
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The fate of the patients who lived for at least one year is shown in Table 2. 
Five of these 9 recipients died subsequent to one year, in 2 cases from chronic 
homograft rejection and hepatic insufficiency. The 3 other late deaths were 
caused by carcinomatosis from the hepatomas for which the operations had been 
originally performed. Actually 2 additional deaths beyond those shown in 
Table 2 were also caused by hepatoma but before the end of the first post-
operative year. The liver homograft of one of the latter patients 143 days post-
transplantation is shown in Fig. Hi. The hepatic homograft had been virtually 
replaced by metastases of the same hepatoma which originally destroyed the 
native liver. 
Table 2. 9 one year survivors. 
Alive 4 / g 
Died 5/9 
12 months 
14montlu-l 
15 mOllths 
15monthb 
30 months 
1-21h years 
1-21/2 years 
Carcinoma 
Carcinoma 
Carcinonm 
Liver failure 
Liver failure 
The curability of hepatoma: Our cure rate of hepatoma by the operation of 
transplantation is actually limited to only 1 case out of 7 in which chronic 
survival was obtained and in which long enough follow ups were therefore 
ava.ilable to permit meaningful observations. In the exeeptional patient, the 
hepatoma was an incidental finding in a liver which was the site of biliary 
atresia (Fig. 17). Obviously, a decision for auxiliary transplantation in this case 
would have cost the patient her life. Instead, there is no evidenee of metastases, 
almost a year after orthotopie transplantation. In this patient serum feto-
protein, a primitive alpha! globulin that is produced by hepatoma tissue was 
present in signifieant quantities prior to operation. After the liver replacement 
the abnormal protein slowly disappeared from the circulation over a period of 
some months (Fig. 18). In a number of other patients with hepatoma who were 
not cured, fetoprotein in the serum invariably persisted and in 2 cases, this 
finding was a tip-off that recurrence was present, many months before meta-
stases became apparent by any other criterion. These analyses were performed 
by Dr. ELLIOT ALPERT of the Robert Bent Brigham Hospital, Boston. 
In leaving this subject, I would like to summarize by saying that because of 
the high rate of recurrent carcinoma in our own experience, it has become policy 
in cases of hepatoma to consider liver replacement only under the most ex-
eeptional circumstances. This does not mean that some recipients with hepa-
toma cannot be cured nor does it imply critism of other transplantation groups 
who persist in similar therapeutic efforts. In fact, besides one of our reci-
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pienti'!, one of CAi~bDp Cambridge patients has no evidence at all of tumor 
recurrence and has probably been cured; J)"\LOZE of Montreal has made a similar 
observation. 
Biliary atresia: Whatever the virtues and fa,ults of liver replacement for 
hepatoma, far more desirable candidates for the procedures are those without 
neoplasms. On the average, the performance of orthotopic transplantation for 
benign disease is more difficult since the patients tend to be sicker, have more 
advanced portal hypertension, and, if the diagnosis is biliary atresia, as it has 
been in 15 of our patientB, an increased incidence of vascular anomalies can be 
anticipatcd. Nevertheless, the most lengthy followups in the world after liver 
transplantation have been in patients who had biliary atresia. The longest 
survivor died about 2 months ago in Denver after 21/2 years. The course of the 
ncxt one is shown in Fig. 19. The child has perfectly normal hepatic function 
after 2 years and 3 months. 1 call your attention to the fact that ALG is still 
being adrn inistered. 
Cirrhosis: So far there have been few patients with cirrhosis who have bene-
fited from liver transplantation. However, in Fig. 20 is an example of a success-
ful outcome in a special kind of cirrhosis, namely that of Wilson's disease. 
Thc 11 year old child was admitted in hepatic precoma. After liver replacement, 
he had a grave rejection crises, the most severe one we have ever seen with 
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Fig. 18. Serial fetoprotein determinations in the patient whose liver contained an unexpected 
hep:ctonm (Fig. 17). Note the gradual disappearance of the primitiye alpha 1 globulin. Tho 
amd.':ws \\Tn' performed b:v Dr. ELLIOT ALPEltT of the Robert Bent Brigham Hospital, 
BostOll. 
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Fig. 19. The course of a four year old child after orthotopic liver transplantation for the 
indication of biliary atresia .. Note the rejection episodes at one and two months which 
,,-ere easily eont.rolled. The patient lla~ perfect liver function 21/4 years after operation. 
recovery. His bilirubin rose to 48.6 mg% (Fig. 20) but eventually the process 
was reversed so that now he has completely normal liver function 14 months 
later. As mentioned earlier, most of the chemical features of the rejection episode 
were those of hiliary obstruction rather than hepatic parenchymal necrosis. 
A number of special studies were clone including measurement of the copper 
content of the excised liver as well as the biopsicd homograft after 6 months. 
Plasma eeruloplasmins and urine copper excretion were also quantitated. After 
transplantation the results of all these analyses became normal. Thus, insofar as 
can be determined in this recipient, an inborn error of copper metabolism was 
cured by provision of a new liver. It is possible that further study of this and 
similar cases will permit identification of the basic cellular defect in 'Wilson's 
disease and resolution of the controycrsies about its real etiology. 
There are rewards as well as responsibilities of being a celebrity. Shown in 
Fig.21 is the celebrated patient talking in Houston recently to 2 other young 
men, NEIL ARMSTRONG and Buzz ALDRON, who took a well publicized stroll on 
the moon 14 months ago, a few weoks after the boy's liYer replacement. I would 
not like to have to decide whose courage was of the higher order. 
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Hepatitis: Before closing I would like to record another case in addition to the 
33 consecutive ones with potential long term followup. Two months ago, a 
28 year old woman with chronic active hepatitis was treated with orthotopic 
liver transplantation. :For at least 2 years before operation and even on the day 
of liver replacement, immunodiffusion tests for the Australia (Au) antigen had 
been positive. After operation, the Au antigen disappeared and it has not since 
been found in any of the subsequent blood specimens. Two months after opera-
tion, the patient has not had a rejection and is in excellent condition. Frankly, 
we were quite astonished by the disappearance of the Australia antigen which 
has been widely assumed to represent the actual serum hepatitis virus. The 
findings in Table 3 provide striking evidence for an essentially exclusive hepatic 
source of the antigenic factor, at least in the patient under discussion. They do 
not shed light on whether this was the actual virus or something manufactured 
by the liver after induction by the virus. If it was virus and the native liver was 
a "carrier" organ, the use of an auxiliary hepatic graft might be subjected to an 
extra risk that was avoided by the orthotopic procedure. 
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Fig. 20. The course of a child with Wilson's disease whose diseased liver was replaced with 
a cadaveric homograft. Note the tremendous rejection episode which reached its peak 
after 5 weeks but which ,vas completely reversed. The child has perfect hepatic function 
after 15 months. In addition, his defective copper metabolism probably has been cured. 
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Fig.21. Liver (boy) and kidney (girl) homograft recipients with moon walking friends. 
(See text for details.) 
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Table 3. Australia antigen and antibody tests. 
Days post-up. Pre 1 2 3 6 9 12 16 19 23 30 37 44 51 
A.u antigen 
-+- - - - - - - - - - - - - -
Anti-Au 
antibody - - - . - - - - - - - - - - -
Summary 
Perhaps it is foolish to attempt to summarize a subject which I have had time 
to review only superficially in the first place. However, I do believe that the 
following concluding remarks would be in order. First, hepatic transplantation 
has passed through the feasibility stage of development since survival of humans 
for as long as 21/2 years has been achieved following removal of the liver and its 
replacement with a cadaveric homograft. Oonsequently, the position can now be 
taken that liver transplantation is a legitimate albeit impcrfect form of treat-
ment. I now believe that with the demonstration of chronic survival, liver 
transplantation should be considered before the prospective recipient has 
reached an agonal condition, a circumstance that was more or less insisted upon 
in our early trials. If patients come to treatment at a some'what earlier time, the 
results will of course improve. Personally, I am certain that the patient who 
receives a technically satisfactory liver replacement has at least as good a 
prognosis and possibly a better one than the renal recipient since the problems 
of immunologic control are probably inherently less difficult. The prime indica-
tion for liver transplantation is benign hepatic disease. If the procedure is used 
to treat hepatoma, there is a high recurrence rate of tumor, 86 % in our hands. 
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